The framework of the products behind Russell Health’s mission to provide physicians with products and tissues to help the body heal itself.
Today we are a leader in advanced wound care, dental, cosmetic and sports medicine with significant scientific, clinical, operational and commercialization expertise. We aim to contribute to human welfare by application of regenerative medicine in the research, education, distribution and sale of amniotic fluid products that alleviate pain, restore health, restore beauty and extend life. Russell Health is devoted to advancing access and quality care in the area of regenerative medicine to help people suffering from a variety of inflammatory and degenerative conditions. Our credo stems from a belief that “consumers, employees and the community are all equally important.” This statement shows that we are passionate about inclusivity and treating everyone with absolute respect and care.
Stem Cell Recruitment (SCR) Facial™ combines DermaFlo™ and our patent-pending SCR Facial™ Procedure Guide that utilizes a minimally invasive technique. DermaFlo™ is an acellular, chorion-free, pure amniotic fluid product. Amniotic fluid surrounds a baby during pregnancy and has evolved over the mellenia to create the ideal environment for fetal development. This complex fluid is a rich source of nutrients, cytokines and growth factors that manage cellular activity. Russell Health’s tissue bank partner receives amniotic fluid from full-term C-section mothers who agree to donate their amniotic fluid to help others. All donors comply with our tissue bank’s extensive screening policy to ensure the fluid is safe for patient use. Patients have reported a dramatic improvement the appearance of aging, damaged, and post-procedure skin.
The biological components in amniotic fluid help to stimulate collagen production, healthy circulation, antioxidant activity and cellular renewal. Physicians have also reported that this ground-breaking therapy helps to diminish the appearance of post acne scarring and soothe skin traumas. This pure amniotic fluid will not clog pores, leave a greasy feel or irritate sensitive skin.
The Growth Differentiation Factor 11 (GDF11) in amniotic fluid is being referred to as the “Fountain of Youth” protein by researchers at Harvard. A recent study showed that a protein called GDF11 helps explain why young blood can rejuvenate several tissues, such as dermal tissues.
The Stem Cell Recruitment (SCR) Facial™ follows our patent-pending SCR Facial™ procedure that micro needles amniotic fluid into the epidermal layer of the skin on the face and neck. The amniotic fluid helps to promote the body’s own healing process to assist in the reconstruction and regeneration of injured tissue within the epidermal layer.
In January 2017, Ryan Salvino and Jonathan Benstent founded Russell Health, Inc., on the premise of helping others achieve pain relief and healing with regenerative medicine derived from acellular placental tissue and fluid products.
Salvino and Benstent were childhood friends who grew up in the suburbs of Chicago. Both attended Butler University in Indianapolis, where they bonded over a mutual passion for en-trepreneurship. By the early 2010s, both had moved to the Chicagoland area — Salvino working on an MBA, and Benstent studying advanced software engineering.
Inspired by the positive effects that amniotic fluid and placental tissue has on the body to promote healing and decrease inflammation, Salvino and Benstent founded Russell Health, Inc., with the goal of providing medical professionals with the tools to treat patients with Stem Cell Recruitment™. This led to the creation of the Stem Cell Recruitment Facial™ treatment utilizing DermaFlo™. Stem Cell Recruitment (SCR) Facial™ combines DermaFlo™ and the patent-pending SCR Facial™ Procedure Guide that utilizes a minimally invasive technique. DermaFlo™ is an acellular, chorion-free, pure amniotic fluid product that manages the cellular activity within the dermal layer. Patients have reported improved laxity and coloration of skin and reduction of fine lines and definition of jawline, as well as diminished appearance of post acne scarring.
DISCLAIMER: Stem Cell Recruitment™(SCR), Stem Cell Recruitment Therapy™(SCRT), SCR Facial™, DermaFlo™, OrthoFactor™ and Vivaderm™ are trademarks of Russell Health, Inc. The treatments described on this marketing are not considered to be standard of care for any condition or disease. SCR, SCRT, SCR Facial and Vivaderm™ attempt to utilize acellular, minimally manipulated tissue allografts and are comprised of tissue allograft components intended for homologous use to supplement tissue. SCRT products are classified by the Food and Drug Administration (FDA) as Human Cell, Tissue and Cellular and Tissue-Based Products (HCT/P) that are regulated solely under section 361 of the Public Health Service (PHS) Act. FDA recognizes that human tissue was designed, or evolved, to perform certain functions in the human body with exquisite safety and effectiveness. See more information about safety and compliance at www.russellhealth.com.